..And the MMJ Phytotech website has had several updates over the past couple of days, but still needs further updating as at today. Satipharm sites don't appear to have been updated yet.
Previously - http://mmjphytotech.com.au/product-pipeline/products-and-solutions/- to my memory, advised that the buccal patches and vaporiser were in progress, and now the "Pipeline" is basically a blank web page.
However, updated page -http://mmjphytotech.com.au/corporate-profile/vision-strategy/ - now includes a vision including "PhytoTech Therapeutics is developing a number of products including an oral capsule and buccal patch...", oral pills, and without mention of the vaporiser.
Different from Vapora, Canigma is developing a stationary device which will vaporize ground buds in capsules. The R&D team is focused on maximizing the vaporization of cannabis from the solid phase to the gaseous phase by optimizing the interplay between heating and air flow. The company has now built its second prototype which it says will deliver a consistent dose in a user friendly and elegant manner.
Canigma received a $250 K investment towards patenting and the development of their proof-of-concept from MMJ PhytoTech, a public company based in Perth, Australia. PhytoTech had plans to develop a vaporizer-inhaler internally but, after meeting with Canigma during a trip to Israel, decided to invest in their technology.
MMJ Price at posting:
34.5¢ Sentiment: Buy Disclosure: Held
